The types of cancers studied in relation to NOD2 polymorphisms included gastric cancer and MALT lymphoma, colorectal cancer (CRC), melanoma, endometrial cancer, pancreatic cancer, breast cancer, non-Hodgkin lymphoma, laryngeal cancer, lymphocytic leukaemia and ovarian cancer. This evidence concerns the gene NOD2 and familial pancreatic carcinoma.